KANGPU BIOPHARMACEUTICALS, LTD.
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
KANGPU BIOPHARMACEUTICALS, LTD.
Social Links:
Industry:
Biopharma Clinical Trials Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.kangpugroup.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
52.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS IIS
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Bioheng
Bioheng is a high-tech R&D innovation company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Nagoya Institute of Clinical Pharmacology
Nagoya Institute of Clinical Pharmacology is a professional service company.
QnQuality Pharmaceuticals
QnQuality Pharmaceuticals is a drug R&D company.
Current Employees Featured
Founder
Investors List
Shining Capital
Shining Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Zhongguancun Kaiyuan Capital
Zhongguancun Kaiyuan Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Lapam Capital
Lapam Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Yijing Capital
Yijing Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
ABC International
ABC International investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Ruihe Venture Capital
Ruihe Venture Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Furong Capital
Furong Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Shenzhen Guozhong Venture Capital Management
Shenzhen Guozhong Venture Capital Management investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Official Site Inspections
http://www.kangpugroup.com
- Host name: 210.22.152.218
- IP address: 210.22.152.218
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
